Lyfur-CV 625 Tablet
Images are for reference. Actual packaging may vary.
Strip of 6 tablets • TabletPrescription requiredSchedule H
Lyfur-CV 625 Tablet
Cefuroxime (500mg) + Clavulanic Acid (125mg)
₹500.00
Strip of 6 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Cefuroxime 500 mg
+1 more active ingredient
How It Works
Cefuroxime binds to penicillin-binding proteins, inhibiting peptidoglycan synthesis and compromising bacterial cell wall integrity.
Medicine Strength
500 mg
All Active Ingredients
Cefuroxime500 mg
Clavulanic Acid125 mg
Uses & Benefits
Medical applications
InfectionBacterialNauseaSkin
Lyfur-CV 625 Tablet is a combination antibiotic formulation containing Cefuroxime 500 mg and Clavulanic Acid 125 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefuroxime, a second-generation cephalosporin, exhibits bactericidal activity by inhibiting bacterial cell wall synthesis, thereby effectively targeting both Gram-positive and Gram-negative organisms.
Read full descriptionShow less
Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Cefuroxime by preventing the enzymatic degradation of the antibiotic by beta-lactamase-producing bacteria, thus extending its spectrum of activity against resistant strains. Lyfur-CV 625 is indicated for respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and sinusitis.
The combination is particularly useful in infections caused by beta-lactamase-producing pathogens where monotherapy with Cefuroxime may be inadequate. It is administered orally and is generally well tolerated, with common adverse effects including gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Caution is advised in patients with a history of hypersensitivity to beta-lactams.
Dosage should be adjusted according to the severity of infection and renal function. Lyfur-CV 625 offers a potent and reliable therapeutic option in managing resistant bacterial infections.
Dosage & How to Use
How to use Lyfur-CV Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lyfur-CV 625 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Consuming alcohol with Lyfur-CV 625 Tablet does not cause any harmful side effects.
High Risk
Pregnancy
Lyfur-CV 625 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Not relevant, as Lyfur-CV 625 Tablet is intended for use in hospitalised patients.
Exercise Caution
Liver
There is limited information available on the use of Lyfur-CV 625 Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
Breastfeeding
Lyfur-CV 625 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Consult Doctor
Kidney
There is limited information available on the use of Lyfur-CV 625 Tablet in patients with kidney disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Lyfur-CV 625 Tablet
